FDA Inspection 1002288 — Baton Rouge General Medical Center

Baton Rouge General Medical Center — FEI 1000221071

The FDA completed an inspection of Baton Rouge General Medical Center on February 17, 2017 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 17, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Baton Rouge, LA (United States)